Assignee
ARIAD PHARMA INC
US·49 granted patents·28 pending applications·655 citations·filing 1994–2023
Top patents by PatentIndex Score
77 records- 0195US9493470B2Crystalline forms of 3-(imidazo[1,2-B] pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl) methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2013·Granted Nov 15, 2016·16 cites·17 claims
- 0294US9611283B1Methods for inhibiting cell proliferation in ALK-driven cancersARIAD PHARMA INC·Filed 2014·Granted Apr 4, 2017·16 cites·17 claims
- 0394US9273077B2Phosphorus derivatives as kinase inhibitorsARIAD PHARMA INC·Filed 2013·Granted Mar 1, 2016·13 cites·51 claims
- 0493US9029533B2Substituted acetylenic imidazo[1,2-A]pyridazines as kinase inhibitorsARIAD PHARMA INC·Filed 2013·Granted May 12, 2015·14 cites·17 claims
- 0593US6150527ASynthetic multimerizing agentsARIAD PHARMA INC·Filed 1997·Granted Nov 21, 2000·78 cites·51 claims
- 0692US10227342B2Heteroaryl compounds for kinase inhibitionARIAD PHARMA INC·Filed 2015·Granted Mar 12, 2019·7 cites·14 claims
- 0791US9796712B2Heteroaryl compounds for kinase inhibitionARIAD PHARMA INC·Filed 2017·Granted Oct 24, 2017·6 cites·15 claims
- 0891US9278971B2Substituted acetylenic pyrazolo[1,5-a]pyrimidines as kinase inhibitorsARIAD PHARMA INC·Filed 2014·Granted Mar 8, 2016·10 cites·11 claims
- 0991US8778942B2Substituted acetylenic imidazo[1,2-A]pyrazine compounds as kinase inhibitorsARIAD PHARMA INC·Filed 2013·Granted Jul 15, 2014·11 cites·19 claims
- 1091US6420384B2Proton pump inhibitorsARIAD PHARMA INC·Filed 2000·Granted Jul 16, 2002·32 cites·9 claims
- 1190US6878697B2Phenylamino-pyrimidines and uses thereofARIAD PHARMA INC·Filed 2002·Granted Apr 12, 2005·26 cites·68 claims
- 1290US6015709ATranscriptional activators, and compositions and uses related theretoARIAD PHARMA INC·Filed 1997·Granted Jan 18, 2000·108 cites·44 claims
- 1389US10125136B2Crystalline forms of 3-(imidazo[1,2-B] pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2016·Granted Nov 13, 2018·3 cites·12 claims
- 1488US10662197B2Crystalline forms of 3-(imidazo[1,2-b)pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2018·Granted May 26, 2020·4 cites·11 claims
- 1586US6713462B2Quinolinones and uses thereofARIAD PHARMA INC·Filed 2002·Granted Mar 30, 2004·16 cites·75 claims
- 1685US9834571B2Compounds for inhibiting cell proliferation in EGFR-driven cancersARIAD PHARMA INC·Filed 2016·Granted Dec 5, 2017·2 cites·16 claims
- 1785US5710129AInhibitors of SH2-mediated processesARIAD PHARMA INC·Filed 1995·Granted Jan 20, 1998·61 cites·8 claims
- 1884US9834521B2Choline kinase inhibitorsARIAD PHARMA INC·Filed 2014·Granted Dec 5, 2017·4 cites·1 claims
- 1984US6482852B2Bicyclic signal transduction inhibitors, compositions containing them & uses thereofARIAD PHARMA INC·Filed 2001·Granted Nov 19, 2002·20 cites·81 claims
- 2084US2024083902A1Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2023·Application pending·0 cites
- 2183US6573295B2Bicyclic signal transduction inhibitors, compositions containing them & uses thereofARIAD PHARMA INC·Filed 2001·Granted Jun 3, 2003·17 cites·81 claims
- 2283US6207397B1In vitro fluorescence polarization assayARIAD PHARMA INC·Filed 1997·Granted Mar 27, 2001·80 cites·11 claims
- 2380US7709020B2Implantable device comprising phosphorus-containing macrolidesARIAD PHARMA INC·Filed 2007·Granted May 4, 2010·2 cites·4 claims
- 2480US2022081440A1Substituted acetylenic pyrazolo[1,5-a]pyridine compounds as kinase inhibitorsARIAD PHARMA INC·Filed 2021·Application pending·0 cites
- 2579US11192896B2Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2021·Granted Dec 7, 2021·0 cites·18 claims
- 2678US11192895B2Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2021·Granted Dec 7, 2021·0 cites·24 claims
- 2778US11192897B2Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2021·Granted Dec 7, 2021·0 cites·23 claims
- 2877US11384086B2Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1- yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2021·Granted Jul 12, 2022·0 cites·19 claims
- 2977US11001580B2Aminothiazole compounds as c-Kit inhibitorsARIAD PHARMA INC·Filed 2017·Granted May 11, 2021·1 cites·14 claims
- 3077US2024208960A1Aminothiazole compounds as c-kit inhibitorsARIAD PHARMA INC·Filed 2023·Application pending·0 cites
- 3176US11117883B2Benzimidazole compounds as c-Kit inhibitorsARIAD PHARMA INC·Filed 2017·Granted Sep 14, 2021·1 cites·7 claims
- 3275US11180482B2Anilinopyrimidines as haematopoietic progenitor kinase 1 (HPK1) inhibitorsARIAD PHARMA INC·Filed 2017·Granted Nov 23, 2021·2 cites·12 claims
- 3375US2020231588A1Bicyclic Heteroaryl CompoundsARIAD PHARMA INC·Filed 2019·Application pending·0 cites
- 3474US11279705B2Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2020·Granted Mar 22, 2022·0 cites·3 claims
- 3573US2020317705A1Phosphorous derivatives as kinase inhibitorsARIAD PHARMA INC·Filed 2019·Application pending·0 cites
- 3672US11427605B2Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl) phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] phenyl} pyrimidine-2,4-diamineARIAD PHARMA INC·Filed 2020·Granted Aug 30, 2022·0 cites·8 claims
- 3771US11753404B2Aminothiazole compounds as c-Kit inhibitorsARIAD PHARMA INC·Filed 2021·Granted Sep 12, 2023·0 cites·4 claims
- 3871US7132427B2Quinazolines and uses thereofARIAD PHARMA INC·Filed 2002·Granted Nov 7, 2006·5 cites·22 claims
- 3970US6960572B2Indolinones and uses thereofARIAD PHARMA INC·Filed 2002·Granted Nov 1, 2005·6 cites·30 claims
- 4070US6706699B2Quinolines and uses thereofARIAD PHARMA INC·Filed 2002·Granted Mar 16, 2004·5 cites·44 claims
- 4169US7115589B2Purine derivativesARIAD PHARMA INC·Filed 2000·Granted Oct 3, 2006·4 cites·20 claims
- 4269US2019031656A1Substituted acetylenic pyrazolo[1,5-a]pyridine compounds as kinase inhibitorsARIAD PHARMA INC·Filed 2018·Application pending·0 cites
- 4367US6576766B1Signal transduction inhibitors, compositions containing themARIAD PHARMA INC·Filed 1998·Granted Jun 10, 2003·12 cites·73 claims
- 4467US6251620B1Three dimensional structure of a ZAP tyrosine protein kinase fragment and modeling methodsARIAD PHARMA INC·Filed 1997·Granted Jun 26, 2001·30 cites·7 claims
- 4566US10934317B2Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl) phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] phenyl} pyrimidine-2,4-diamineARIAD PHARMA INC·Filed 2019·Granted Mar 2, 2021·0 cites·13 claims
- 4666US2021186994A1Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamineARIAD PHARMA INC·Filed 2021·Application pending·0 cites
- 4765US2019218212A1Heteroaryl compounds for kinase inhibitionARIAD PHARMA INC·Filed 2019·Application pending·0 cites
- 4864US2022064144A1Benzimidazole compounds as c-kit inhibitorsARIAD PHARMA INC·Filed 2021·Application pending·0 cites
- 4964US2020048288A1Phosphorous derivatives as kinase inhibitorsARIAD PHARMA INC·Filed 2019·Application pending·0 cites
- 5063US9573934B2Methods and compositions for the synthesis of multimerizing agentsARIAD PHARMA INC·Filed 2015·Granted Feb 21, 2017·0 cites·20 claims
Showing the top 50 of 77 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ARIAD PHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →